Prostate Cancer Disparities Among Black Men: What’s at Stake
Prostate cancer touches millions of families, but for many Black men, the risk is sharper and the climb steeper. The numbers are stark: Black men are 70% more likely to develop prostate cancer than white men. That single figure signals more than a statistic—it points to differences in screening, access to care, and outcomes that deserve focused attention and action.
Catalyst for Change: A Forum for Action and Awareness
The National Civil Rights Museum is hosting a panel discussion, “Tackling Prostate Cancer Disparities in Black Men,” as part of its Catalyst for Change Speaker Series. The series exists to foster dialogue and bring health equity issues into plain view. By centering this conversation, the museum extends its mission beyond history and memory to advocacy, amplifying the call for social justice and public health equity today.
Event Details
The panel will be offered in a hybrid format, so you can attend in person or stream it online. The program, scheduled for a future date, brings together clinicians, advocates, and survivors who will share what they know and what they’ve lived. Expect a focus on practical ways to expand access to care, increase timely screenings, and pursue strategies that can narrow the gap Black men face when it comes to prostate cancer.
Meet the Expert Panelists
This conversation draws strength from a range of perspectives. The panel includes:
- Dr. Duane Loynes, an Assistant Professor and advocate for Equity & Culture in health, who speaks to how systems shape patient experience and care.
- Dr. Walter Rayford, a Urologist and Associate Professor, bringing both clinical experience and academic insight to prevention, diagnosis, and treatment.
- Clarence Williamson, a Prostate Cancer Survivor and co-founder of an awareness organization, sharing lessons learned from the patient side of the journey.
- Ken Carpenter, a survivor and healthcare provider, focused on serving his community and supporting others through care and recovery.
Addressing Health Disparities: A Collective Responsibility
Dr. Russ Wigginton, President of the Museum, underscores the urgency of closing the equity gap in healthcare. Advances in screening and treatment have improved outcomes for many, yet racial disparities persist and profoundly affect Black men diagnosed with prostate cancer. Naming the problem is essential; acting together—patients, providers, institutions—moves the needle.
Working in Partnership with Pfizer
The National Civil Rights Museum has partnered with Pfizer to present this program, signaling a shared commitment to meet these challenges head-on. The aim is twofold: raise awareness and surface realistic, actionable steps to reduce barriers to care and improve quality of life for those affected by prostate cancer.
Why Community Engagement Matters
Change grows when communities lead it. This event invites not only healthcare professionals but also neighbors, family members, caregivers, and anyone who wants to understand what prostate cancer disparities mean in everyday life. As Angel Riemer from Pfizer notes, creating space for open discussion is vital. The conversation is most powerful when it includes many voices—and when it turns talk into coordinated action.
What Attendees Can Expect
Come for practical information, stay for honest stories. You’ll hear from experts and survivors, and you’ll leave with clearer next steps—around screening, access, and advocacy. A reception will follow the panel, offering time to connect with panelists and other attendees, compare notes, and build relationships that continue the work beyond the event.
About the National Civil Rights Museum
Located at the historic Lorraine Motel, the NATIONAL CIVIL RIGHTS MUSEUM stands as a living classroom for civil rights education and advocacy. Recognized as a leading institution, the museum welcomes visitors from around the world and keeps the focus on social justice and equality—linking the past to the present so people can act with clarity now.
As a Smithsonian Affiliate, the museum holds a distinctive place in American history and culture. Its exhibitions and programs reflect the persistence of human rights movements over time and the ongoing work required to protect equity in every sphere of life, including health.
Frequently Asked Questions
What’s the main goal of the Catalyst for Change panel?
The panel aims to spotlight the 70% higher risk Black men face for prostate cancer and to explore concrete ways to close that gap—through earlier screening, stronger access to care, and strategies that meet people where they are.
Who’s participating in the discussion?
The panel brings together healthcare experts and survivors, including Dr. Duane Loynes, Dr. Walter Rayford, Clarence Williamson, and Ken Carpenter, each offering a different lens on prevention, treatment, and lived experience.
How can I take part in the event?
You can join in person or watch via an online stream. Registration is encouraged for all attendees so organizers can plan for a smooth, accessible experience.
Why is this conversation especially important for Black men?
Because Black men are 70% more likely to develop prostate cancer than white men, timely screening and equitable access to care can be the difference between early detection and late diagnosis—and that difference matters.
What role does Pfizer play?
Pfizer is partnering with the National Civil Rights Museum to support this event, helping elevate awareness and identify tangible steps that reduce barriers to care and improve quality of life for those affected by prostate cancer.
